ASSOCIATION OF PLATELET INDICES WITH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 36
Abstract
BACKGROUND Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease of unknown aetiology that mainly affects peripheral joints in a symmetric pattern. Prevalence of RA is approximately 1% worldwide, being two to three times more common in women than men. Effective management in RA requires close monitoring of disease activity. Platelet activation is an important event in synovial inflammation, but very few studies have used platelet indices to assess inflammation. Thus, the aim of the study was to correlate the platelet indices (platelet count, mean platelet volume and platelet distribution width) with disease activity in Rheumatoid Arthritis. MATERIALS AND METHODS This descriptive comparative study was conducted among 60 RA patients and 30 healthy controls within the age group of 30 to 70 years. Every consecutive RA patient who attended the Rheumatology Outpatient Department was included in the study. The severity of RA was assessed by the Disease Activity Score Calculator for Rheumatoid Arthritis (DAS-28). The platelet indices assessed in the study include platelet count, Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW) obtained from their CBC report. The study population was divided into three groups. Group I (Moderate disease activity) with DAS-28 score of 3.2-5.1; Group II (High disease activity) with DAS-28 score above 5.1. Thirty patients in Group I and thirty in Group II were taken for the study. Group III: 30 healthy controls who attended the Master Health Check-Up Department. Data analysis was done by using SPSS software and independent t-test. P value < 0.05 was taken as statistically significant. RESULTS There was statistically significant increase in platelet count, decrease in MPV and PDW in high-grade RA patients when compared with normal individuals (p= 0.004, p= 0.001, p= 0.019 respectively). We also found similar statistical significance between high and moderate grade RA patients (p= 0.001 for platelet count, p= 0.007 for MPV and p= 0.012 for PDW). CONCLUSION Our study suggests that platelet indices can be considered as inflammatory markers for disease activity in RA. However, further studies with larger number of patients are warranted to cross validate our findings.
Authors and Affiliations
Shuba N, Praba V, Prithiviraaj P
LASER ASSISTED SUB EPITHELIAL KERATECTOMY FOR HYPEROPIA USING 213 NM WAVELENGTH SOLID STATE LASER, 3 YEAR FOLLOW UP STUDY OF REFRACTIVE AND VISUAL OUTCOMES
[b] PURPOSE:[/b] To evaluate the visual and refractive outcomes, using 213 nm solid lasers for the correction of broad range of hyperopia, covering pediatric age group to presbyopic age group. [b]MATERIALS AND M...
MICROBIAL KERATITIS- MICROBIAL PATTERN IN A TERTIARY CARE CENTRE OF A METROPOLITAN CITY
BACKGROUND Microbial keratitis is a potentially vision threatening state requiring prompt diagnosis & treatment, and is a leading cause of preventable blindness. We wanted to study the spectrum and sensitivity of microbi...
A STUDY OF PROFILE AND PATTERNS OF “JOINT INVOLVEMENT” IN UNDER 15 YEARS AGE GROUP CHILDREN WITH ACUTE RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE
[b]CONTEXT (BACKGROUND)[/b]: Acute Rheumatic fever / Rheumatic Heart disease is the most common acquired childhood heart disease diagnosis made in India. Poly Arthritis is one of the common manifestations of the...
UMBILICAL VEIN INJECTION OF MISOPROSTOL VERSUS NORMAL SALINE FOR THE TREATMENT OF RETAINED PLACENTA IN A TERTIARY CARE CENTRE- A NON-RANDOMISED CONTROLLED TRIAL
BACKGROUND Many cases of PPH are associated with retained placenta, having great impact on maternal mortality and morbidity worldwide. The aim of our study was to evaluate the efficacy of intraumbilical misoprostol versu...
A STUDY OF VOICE CHANGES IN SPASMODIC DYSPHONIA AFTER BOTULINUM THERAPY
BACKGROUND Spasmodic dysphonia is a neurological disorder, which can give the voice a strained quality. There is currently no cure for spasmodic dysphonia. The most common treatment for spasmodic dysphonia is t...